Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The purpose of this prospective, multi‐center, randomized, controlled non‐inferiority clinical trial was to evaluate the safety and efficacy of Cera™ patent foramen ovale occluders developed by Lifetech Scientific (Shenzhen) Co., LTD for the treatment of cryptogenic stroke complicated with patent foramen ovale. The study required the implant to follow instructions strictly.
Epistemonikos ID: f55b75621b0c1ffd591842ba2ff475e1a6a560c3
First added on: Feb 19, 2024